Patients with and without loss of hepatitis B virus DNA after hepatitis B e antigen seroconversion have different virological characteristics
Open Access
- 18 November 2005
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 78 (1) , 68-73
Abstract
The characteristic differences between patients with and without loss of hepatitis B virus (HBV) DNA after achieving hepatitis B e antigen seroconversion were analyzed by comparing changes in HBV DNA and HBV core-related antigen levels during a period from 3 years before to 3 years after the seroconversion. Of the 24 seroconverters, 6 (inactive replication group) showed continuous loss of HBV DNA in serum after the seroconversion and the remaining 18 did not lose HBV DNA (active replication group). The HBV DNA level was similar between the two groups, while the HBV core-related antigen level was significantly lower in the active replication group than in the inactive replication group before the seroconversion. The levels of both HBV DNA and HBV core-related antigen decreased remarkably around the time of seroconversion in the inactive replication group, while these levels did not change or decreased slightly in the active replication group. After the seroconversion, the HBV DNA level was significantly higher in the active replication group than in the inactive replication group, while the HBV core-related antigen level was similarly low between the two groups. Because the serum level of HBV core-related antigen mainly reflects that of HBe antigen, the low level of HBV core-related antigen seen after seroconversion in both groups might have contributed to the occurrence of seroconversion. The precore and core promoter mutations which cause diminished excretion of hepatitis B e antigen were significantly more frequent in the active replication group than in the inactive replication group. It was therefore considered that the seroconversion was caused mainly by a decrease in viral replication in the inactive replication group, and mainly by a decrease in HBe antigen production in the active replication group. J. Med. Virol. 78:68–73, 2006.Keywords
This publication has 29 references indexed in Scilit:
- A case‐control study for early prediction of hepatitis B e antigen seroconversion by hepatitis B virus DNA levels and mutations in the precore region and core promoterJournal of Medical Virology, 2003
- Consistently Low Hepatitis B Virus DNA Saves Patients from Hepatocellular Carcinogenesis in HBV-Related CirrhosisIntervirology, 2003
- Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis BHepatology, 2002
- A Case–Control Study for Clinical and Molecular Biological Differences Between Hepatitis B Viruses of Genotypes B and CHepatology, 2001
- Hepatitis B Virus InfectionNew England Journal of Medicine, 1997
- The precore/core promoter mutant (T1762A1764) of hepatitis B virus: clinical significance and an easy method for detectionJournal of General Virology, 1995
- Hepatitis B: global importance and need for controlVaccine, 1990
- MUTATION PREVENTING FORMATION OF HEPATITIS B e ANTIGEN IN PATIENTS WITH CHRONIC HEPATITIS B INFECTIONThe Lancet, 1989
- Formation of transmembraneous hepatitis b e-antigen by cotranslational in vitro processing of the viral precore proteinVirology, 1988
- Targeting of the hepatitis B virus precore protein to the endoplasmic reticulum membrane: after signal peptide cleavage translocation can be aborted and the product released into the cytoplasm.Journal of Cell Biology, 1988